Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Hon Pui

Showing results (511-520 of 611) with videos related to

Pageof 62
Sort By:
Blood|June 30, 2021
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno ConsortiumSwantje Buchmann, Martin Schrappe, Andre Baruchel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007Ching-Hon Pui, Deqing Pei, Alberto S Pappo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 26, 2021
Impact of Risk-Stratified Therapy on Health Status in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report from the Childhood Cancer Survivor StudyStephanie B Dixon, Yan Chen, Yutaka Yasui, et al.
JAMA Oncology|January 27, 2022
Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic LeukemiaShawn H R Lee, Federico Antillon-Klussmann, Deqing Pei, et al.
Genome Research|December 2, 2016
Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBPMaoxiang Qian, Hui Zhang, Shirley Kow-Yin Kham, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2017
Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report From the St. Jude Lifetime CohortWassim Chemaitilly, Zhenghong Li, Matthew J Krasin, et al.
Cancer Cell|April 9, 2024
Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemiaXin Huang, Yizhen Li, Jingliao Zhang, et al.
Blood|November 4, 2015
Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levelsCharles G Mullighan, Sima Jeha, Deqing Pei, et al.
Blood|September 26, 2012
Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor StudyStephanie B Dixon, Yan Chen, Yutaka Yasui, et al.
Pageof 62

Showing results (511-520 of 611) with videos related to

Sort By:
Pageof 62
Blood|June 30, 2021
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno ConsortiumSwantje Buchmann, Martin Schrappe, Andre Baruchel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007Ching-Hon Pui, Deqing Pei, Alberto S Pappo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 26, 2021
Impact of Risk-Stratified Therapy on Health Status in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report from the Childhood Cancer Survivor StudyStephanie B Dixon, Yan Chen, Yutaka Yasui, et al.
JAMA Oncology|January 27, 2022
Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic LeukemiaShawn H R Lee, Federico Antillon-Klussmann, Deqing Pei, et al.
Genome Research|December 2, 2016
Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBPMaoxiang Qian, Hui Zhang, Shirley Kow-Yin Kham, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2017
Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report From the St. Jude Lifetime CohortWassim Chemaitilly, Zhenghong Li, Matthew J Krasin, et al.
Cancer Cell|April 9, 2024
Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemiaXin Huang, Yizhen Li, Jingliao Zhang, et al.
Blood|November 4, 2015
Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levelsCharles G Mullighan, Sima Jeha, Deqing Pei, et al.
Blood|September 26, 2012
Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor StudyStephanie B Dixon, Yan Chen, Yutaka Yasui, et al.
Pageof 62